Overview
Pawel Muranski, MD, trained as a Hematologist and Oncologist at the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland where he subsequently worked as a faculty in the Stem Cell Allogeneic Transplantation Section. He joined Columbia University in 2017 as the Director of Cellular Immunotherapy. Dr. Muranski specializes in bone marrow transplant (BMT).
Areas of Expertise / Conditions Treated
- Bone Marrow Transplantation
- Leukemia
- Lymphoma
Academic Appointments
- Assistant Professor of Medicine at CUMC
Administrative Titles
- Director of Cellular Immunotherapy Laboratory
- Principal Investigator at the Columbia Center for Translational Immunology (CCTI)
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
Affinity Health Plan
Amida Care
Cigna
Emblem/GHI
Emblem/HIP
Empire Blue Cross/Blue Shield
Empire Blue Cross Blue Shield HealthPlus
Fidelis Care
Healthfirst
Local 1199
MagnaCare (National)
Medicare
Multiplan
MVP Health Care
RiverSpring
UnitedHealthcare
VNSNY CHOICE
WellCare
World Trade Center Health Plan
Credentials & Experience
Education & Training
- MD, Medical University of Warsaw, Poland
- Residency: AMITA Health / Saint Francis Hospital, Evanston, Illinois
- Fellowship: National Institutes of Health (NIH), Bethesda, Maryland,
- Fellowship: National Cancer Institute (NCI), Bethesda, MD
Committees, Societies, Councils
- Member, Herbert Irving Comprehensive Cancer Center
Board Certifications
- Internal Medicine
- Hematology
Honors & Awards
- 2025: Agilent Research Catalyst (ARC) Award
Research
At NHLBI, Dr. Muranski has conducted studies on using T cells for prevention and treatment of common viral infections affecting bone marrow transplant recipients. He has also developed first-in-human study of adoptive immunotherapy for patients with JC virus-associated Progressive Multifocal Leukoencephalopathy (PML). In addition, he has completed a research fellowship in cancer immunology and immunotherapy at the Surgery Branch, National Cancer Institute, NIH.
He is a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center. His laboratory focuses on developing potent T lymphocytes for adoptive immunotherapy of viral infections and cancer.
Research Interests
- Cancer
- Cellular Immunotherapy
- Immunology
- Immunotherapy
- Progressive Multifocal Leukoencephalopathy (PML)
- T Cells
- Transplant Immunology
- Viral Infections